收稿日期: 2020-07-13
网络出版日期: 2021-05-14
基金资助
国家自然科学基金(81772936);上海交通大学医学院附属国际和平妇幼保健院院级科研基金(GFY5809);上海交通大学医学院高水平地方高校创新团队(SSMU-ZDCX20180800)
Molecular mechanism of apoptosis-inducing factor regulated by FBXO22 and its role in cancer cell apoptosis
Received date: 2020-07-13
Online published: 2021-05-14
Supported by
National Natural Science Foundation of China(81772936);Foundation of International Peace Maternity & Child Health Hospital, Shanghai Jiao Tong University School of Medicine(GFY5809);Innovative Research Team of High-Level Local Universities in Shanghai(SSMU-ZDCX20180800)
目的·挖掘F-box蛋白22(F-box only protein 22,FBXO22)的底物并明确其作用机制,进一步探讨FBXO22在肿瘤细胞凋亡中的作用。方法·利用免疫沉淀联合质谱分析寻找并验证FBXO22的相互作用蛋白凋亡诱导因子(apoptosis-inducing factor,AIF)。采用变性条件下泛素化修饰实验检测FBXO22对AIF泛素化修饰的影响。通过短发夹RNA敲低FBXO22、过表达FBXO22检测AIF的表达水平。利用流式细胞仪检测FBXO22敲低或过表达对结肠癌细胞凋亡的影响。结果·免疫沉淀联合质谱分析显示FBXO22可与AIF结合,变性条件下泛素化修饰实验显示FBXO22可介导AIF的泛素化修饰。敲低FBXO22可上调AIF水平,过表达FBXO22可下调AIF水平。流式细胞术结果显示,敲低FBXO22可促进由甲基硝基亚硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,MNNG)等诱导的结肠癌细胞凋亡,过表达FBXO22则可抑制MNNG等诱导的结肠癌细胞凋亡。结论·FBXO22通过泛素化修饰降解AIF进而调控由AIF介导的结肠癌细胞凋亡。
刘朦迪 , 潘漪莲 , 朱晓娜 , 杨烁 , 杨茜 , 余韵 . FBXO22调控凋亡诱导因子的分子机制及其在肿瘤细胞凋亡中的作用[J]. 上海交通大学学报(医学版), 2021 , 41(4) : 427 -433 . DOI: 10.3969/j.issn.1674-8115.2021.04.003
·To explore the substrate of F-box only protein 22 (FBXO22) and its mechanism, and further study the role of FBXO22 in cancer cell apoptosis.
·The interaction protein of FBXO22, namely apoptosis-inducing factor (AIF), was searched and identified by immunoprecipitation (IP)-coupled liquid chromatograph mass spectrometer/mass spectrometer (LC-MS/MS) technology. The effect of FBXO22 on ubiquitination of AIF was detected by ubiquitin modification assay under denatured conditions. Short hairpin RNA (shRNA) knockdown FBXO22 and overexpression FBXO22 were used to detect the expression of AIF. The effect of FBXO22 knockdown or overexpression on apoptosis of colon cancer cells was detected by flow cytometry.
·IP-coupled LC-MS/MS technology showed that FBXO22 could interact with AIF, and ubiquitin modification assay under denaturing conditions showed that FBXO22 could mediate ubiquitination of AIF. Knockdown of FBXO22 could up-regulate the level of AIF, while overexpression of FBXO22 could down-regulate the level of AIF. The results of flow cytometry showed that knockdown of FBXO22 could promote the apoptosis of colon cancer cells induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), while overexpression of FBXO22 could inhibit the apoptosis of colon cancer cells induced by MNNG.
· FBXO22 regulates AIF-mediated apoptosis of colon cancer cells by ubiquitination and degradation of AIF.
1 | Nandi D, Tahiliani P, Kumar A, et al. The ubiquitin-proteasome system[J]. J Biosci, 2006, 31(1): 137-155. |
2 | Tang Q, Wu P, Chen H, et al. Pleiotropic roles of the ubiquitin-proteasome system during viral propagation[J]. Life Sci, 2018, 207: 350-354. |
3 | Kitagawa K, Kitagawa M. The SCF-type E3 ubiquitin ligases as cancer targets[J]. Curr Cancer Drug Targets, 2016, 16(2): 119-129. |
4 | Jin J, Cardozo T, Lovering RC, et al. Systematic analysis and nomenclature of mammalian F-box proteins[J]. Genes Dev, 2004, 18(21): 2573-2580. |
5 | Vrba L, Junk DJ, Novak P, et al. p53 induces distinct epigenetic states at its direct target promoters[J]. BMC Genomics, 2008, 9: 486. |
6 | Johmura Y, Sun J, Kitagawa K, et al. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence[J]. Nat Commun, 2016, 7: 10574. |
7 | Tian X, Dai S, Sun J, et al. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression[J]. Oncotarget, 2015, 6(26): 22767-22775. |
8 | Sun R, Xie HY, Qian JX, et al. FBXO22 possesses both protumorigenic and antimetastatic roles in breast cancer progression[J]. Cancer Res, 2018, 78(18): 5274-5286. |
9 | Bai J, Wu K, Cao M, et al. SCF FBXO22 targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis[J]. Proceedings of the National Academy of Sciences, 2019, 116(10):201820990. |
10 | Guo F, Liu J, Han X, et al. FBXO22 suppresses metastasis in human renal cell carcinoma via inhibiting MMP-9-mediated migration and invasion and VEGF-mediated angiogenesis[J]. Int J Biol Sci, 2019, 15(3): 647-656. |
11 | Lignitto L, LeBoeuf SE, Homer H, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1[J]. Cell, 2019, 178(2): 316-329.e18. |
12 | Zhu XN, He P, Zhang L, et al. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth[J]. Cell Death Dis, 2019, 10(7): 486. |
13 | Ge MK, Zhang N, Xia L, et al. FBXO22 degrades nuclear PTEN to promote tumorigenesis[J]. Nat Commun, 2020, 11(1): 1720. |
14 | Moubarak RS, Yuste VJ, Artus C, et al. Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis[J]. Mol Cell Biol, 2007, 27(13): 4844-4862. |
15 | Yang H, Xie Y, Yang D, et al. Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma[J]. Oncotarget, 2017, 8(15): 25310-25322. |
16 | Jang KH, Do YJ, Son D, et al. AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration[J]. Cell Death Dis, 2017, 8(1): e2526. |
17 | Joza N, Pospisilik JA, Hangen E, et al. AIF: not just an apoptosis-inducing factor[J]. Ann N Y Acad Sci, 2009, 1171: 2-11. |
18 | Sevrioukova IF. Apoptosis-inducing factor: structure, function, and redox regulation[J]. Antioxid Redox Signal, 2011, 14(12): 2545-2579. |
19 | Lewis EM, Wilkinson AS, Davis NY, et al. Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation[J]. Biochemistry, 2011, 50(51): 11084-11096. |
20 | Wilkinson JC, Wilkinson AS, Galbán S, et al. Apoptosis-inducing factor is a target for ubiquitination through interaction with XIAP[J]. Mol Cell Biol, 2008, 28(1): 237-247. |
21 | Shen SM, Yu Y, Wu YL, et al. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells[J]. Carcinogenesis, 2010, 31(3): 419-426. |
22 | Shen SM, Yu Y, Wu ZX, et al. Apoptosis-inducing factor is a target gene of C/EBPα and participates in adipocyte differentiation[J]. FEBS Lett, 2011, 585(14): 2307-2312. |
23 | Stambolsky P, Weisz L, Shats I, et al. Regulation of AIF expression by p53[J]. Cell Death Differ, 2006, 13(12): 2140-2149. |
24 | Pospisilik JA, Knauf C, Joza N, et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes[J]. Cell, 2007, 131(3): 476-491. |
25 | Vahsen N, Candé C, Brière JJ, et al. AIF deficiency compromises oxidative phosphorylation[J]. EMBO J, 2004, 23(23): 4679-4689. |
26 | Hangen E, Féraud O, Lachkar S, et al. Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis[J]. Mol Cell, 2015, 58(6): 1001-1014. |
27 | Shen SM, Guo M, Xiong Z, et al. AIF inhibits tumor metastasis by protecting PTEN from oxidation[J]. EMBO Rep, 2015, 16(11): 1563-1580. |
/
〈 |
|
〉 |